Gangstem Biotech, Patent on Method for Manufacturing Induced Neural Stem Cells
[Asia Economy Reporter Oh Ju-yeon] Kangstem Biotech announced on the 14th that it has obtained a domestic patent for a method of producing neural stem cells induced from non-neural cells through direct programming and its applications. The company stated, "By precisely controlling the amount of virus containing Sox2 and c-Myc, neural stem cells can be produced solely by the introduction of Sox2 and c-Myc, and the genetic stability and differentiation ability of the produced induced neural stem cells can be confirmed."
Hot Picks Today
18 Years On, Hourly Wages Still Stuck at 20,000 Won... "Who Would Work Here?" Plenty of Orders, But No Workers Left [K-Shipbuilding, The Disappearing Skilled Workers]①
- After-Work Side Job Planners Flock in for '130,000 Won a Month' Allowance, but Side Effects Grow [Financial Microscope]
- CEO’s Salary Exceeds Three Years’ Total Dividends... Worldex, a Department Store of Shareholder Neglect
- "Is She Really a Mother of a 45-Year-Old? The Secret to Youthful Looks of a 70-Year-Old Woman with 2 Million Followers"
- "Where Did the Tire Go?" Loud Noise from Car Shocks Drivers... Driver's Response Even More Baffling
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.